Business Segments and Geographic Data (Tables)

9 Months Ended

Sep. 30, 2013

Business Segment and Geographic Data [Abstract]

Results of operations from business segments

The following tables reflect results of operations from our business segments for the periods indicated below:

Three Months Ended September 30, 2013

	CONSUMER			PHYSICIAN RECURRING			PROFESSIONAL			TOTAL
Revenues	$	36,910		$	7,359		$	1,624		$	45,893
Costs of revenues		4,730			3,272			1,064			9,066
Gross profit		32,180			4,087			560			36,827
Gross profit %		87.2	%		55.5	%		34.5	%		80.2	%
Allocated operating expenses:
Engineering and product development		279			341			185			805
Selling and marketing expenses		26,958			3,370			645			30,973
Unallocated operating expenses		-			-			-			5,972
		27,237			3,711			830			37,750
Operating profit (loss)		4,943			376			(270	)		(923	)
Interest and other financing expense, net		-			-			-			473
Income (loss) before income tax expense	$	4,943		$	376		$	( 270	)	$	( 450	)

Three Months Ended September 30, 2012

	CONSUMER			PHYSICIAN RECURRING			PROFESSIONAL			TOTAL
Revenues	$	49,638		$	5,121		$	1,922		$	56,681
Costs of revenues		7,366			2,811			1,104			11,281
Gross profit		42,272			2,310			818			45,400
Gross profit %		85.2	%		45.1	%		42.6	%		80.1	%
Allocated operating expenses:
Engineering and product development		165			278			185			628
Selling and marketing expenses		24,980			2,575			730			28,285
Unallocated operating expenses		-			-			-			6,231
		25,145			2,853			915			35,144
Operating profit (loss)		17,127			(543	)		(97	)		10,256
Interest and other financing expense, net		-			-			-			(231	)
Income (loss) before income tax expense	$	17,127		$	( 543	)	$	( 97	)	$	10,025

Nine Months Ended September 30, 2013

	CONSUMER			PHYSICIAN RECURRING			PROFESSIONAL			TOTAL
Revenues	$	134,643			20,690		$	5,841		$	161,174
Costs of revenues		19,422			9,217			3,683			32,322
Gross profit		115,221			11,473			2,158			128,852
Gross profit %		85.6	%		55.5	%		36.9	%		79.9	%
Allocated operating expenses:
Engineering and product development		775			982			635			2,392
Selling and marketing expenses		79,293			9,777			1,697			90,767
Unallocated operating expenses		-			-			-			17,899
		80,068			10,759			2,332			111,058
Operating profit (loss)		35,153			714			(174	)		17,794
Interest  and other financing income, net		-			-			-			470
Income (loss) before income tax expense	$	35,153		$	714		$	( 174	)	$	18,264

Nine Months Ended September 30, 2012

	CONSUMER			PHYSICIAN RECURRING			PROFESSIONAL			TOTAL
Revenues	$	142,303		$	15,467		$	8,090		$	165,860
Costs of revenues		22,307			8,095			4,468			34,870
Gross profit		119,996			7,372			3,622			130,990
Gross profit %		84.3	%		47.7	%		44.8	%		79.0	%
Allocated operating expenses:
Engineering and product development		642			863			641			2,146
Selling and marketing expenses		74,673			7,526			2,989			85,188
Unallocated operating expenses		-			-			-			22,593
		75,315			8,389			3,630			109,927
Operating profit (loss)		44,681			(1,017	)		( 8	)		21,063
Interest and other financing expense, net		-			-			-			(862	)
Income before income tax expense	$	44,681		$	( 1,017	)	$	( 8	)	$	20,201

Net revenues and long-lived assets by geographical area

For the three and nine months ended September 30, 2013 and 2012, net revenues by geographic area were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
North America 1	$	35,239	$	38,888	$	122,170	$	121,524
Asia Pacific 2		1,778		9,533		16,980		23,306
Europe (including Israel)		8,083		7,170		19,577		18,623
South America		793		1,090		2,447		2,407
	$	45,893	$	56,681	$	161,174	$	165,860
1 United States	$	30,287	$	31,380	$	98,832	$	101,473
2  Japan	$	205	$	8,144	$	11,455	$	18,318

As of September 30, 2013 and December 31, 2012, long-lived assets by geographic area were as follows:

	September 30, 2013		December 31, 2012
	(unaudited)
North America	$	8,701	$	5,772
Asia Pacific		-		-
Europe (including Israel)		1,300		987
South America		-		-
	$	10,001	$	6,759